Focal Segmental Glomerulosclerosis Market Expanding Rapidly as Major Market Player Oraxion Therapeutics Inc. Enters into an Agreement with Aten Porous

 

Focal Segmental Glomerulosclerosis is presently considered as a set of clinical syndromes sharing a very similar common histopathologic lesion namely, focal scarring in the glomerulus followed by fibrosis, fibrous nodules, and fibric infiltrate. Although various causes may be involved in the pathogenesis of this condition, the most common mechanoreceptor sites of action are the interneurons in the optic nerve and the choroid. The choroid can be damaged due to injuries or diseases like leukemia, lymphoma, myelodysplasia, and so on. Since these choroid sites contain many cell types, a wide variety of cell-damage mechanisms have been proposed to underlie Focal Segmental Glomerulosclerosis. Focal Segmental Glomerulosclerosis is also known as nephrotic syndrome and can be effectively addressed through surgical and non-surgical treatment options.

Increasing prevalence of focal segmental glomerulosclerosis is expected to drive growth of the global focal segmental glomerulosclerosis market during the forecast period. According to the National Organization for Rare Disorders (NORD), in the U.S., focal segmental glomerulosclerosis is expected to affect around 7 people per million people in the general population. However, specific rates of incidence vary with different populations. Increasing burden of focal segmental glomerulosclerosis has led to high demand for treatment options. Hence, these factors are expected to drive growth of the global focal segmental glomerulosclerosis market during the forecast period. Moreover, continuous research and development activities for new treatment options is expected to boost the global focal segmental glomerulosclerosis market growth over the forecast period.

However, high cost of kidney transplants and dialysis coupled with a lack of awareness regarding the disease is expected to hinder the global focal segmental glomerulosclerosis market growth over the forecast period. Among regions, North America is expected to witness significant growth in the global focal segmental glomerulosclerosis market during the forecast period. This is owing to the presence of robust healthcare infrastructure and the availability of reimbursement policies. Furthermore, Asia Pacific is expected to register a robust growth rate over the forecast period, owing to agreements and contracts between key market players.

Key companies involved in the global focal segmental glomerulosclerosis market are Sanofi S.A, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Novartis AG, AbbVie, Inc., Retrophin, Inc., Variant Pharmaceuticals, Inc., Pfizer, Inc., Oraxion Therapeutics Inc., and AstraZeneca plc.

For instance, in February 2018, Oraxion Therapeutics Inc. entered into an Option Agreement with Aten Porous to get exclusive rights for clinical studies. 

Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×

Medical transcription services has tremendously changed the way of delivering patient reports while reducing clinical documentation time

 

Medical transcription services are health reports that are typed out from dictated medical reports by medical professionals, such as doctors, dentists, and physicians. These reports contain vital information regarding a patient's health and are crucial to their care. This service offers data accuracy and data-driven insights for making an easy decision regarding patient treatment and care. Medical transcription services can be classified into Discharge Summary (DS), History and Physical Report (H&P), Operative Note or Report (OP), Consultation Report (CONSULTS), and Pathology Report (PATH) & Radiology Report.

Continuous advancement in medical transcription services is expected to drive the market growth. For instance, in October 2020, ETranscription, a Canadian transcription company, launched its new website and platform to expand its high-quality transcription services. The company has offered a free trial and reduced rates to help hospital streamline their workflow. Moreover, updates support a seamless online transcription process while delivering secure, accurate, and cost-effective services. This service effectively reduces clinical documentation time and enables doctors to plan patient’s treatments. Increasing adoption of technologies such as digital health, telemedicine, and EHR is further anticipated to foster the growth of medical transcription services market in the near future.

From the geographical point of view, North America is expected to gain significant growth over the forecast timeframe and this is attributed to the high adoption rate of medical transcription services in the region. Moreover, increasing distributing agreements among key manufacturer in the region is again anticipated to propel the market growth. For instance, in June 2017, iMedX, a health information and medical documentation solutions company, announced that it has signed a contract with Vizient, Inc. the member-driven health care performance improvement company in the country for transcription services solutions.

 Key Developments:

1.      In December 2019, Amazon Web Services (AWS) has launched a new machine learning service called Amazon Transcribe Medical, which will automatically convert physician consultations and dictated notes from speech to text.

2.      In May 2019, MD office Manager is pleased to announce its integration with Point Click Care, the leading cloud-based software vendor for the long-term and post-acute care (LTPAC) and senior living sectors.

3.      In June 2018, Mediscribes, Inc., a Speech Recognition Technology, Medical Transcription, and Health Information Management Solutions, has been chosen by the GSA as a vendor of choice for medical transcription services and technology for all GSA Member hospitals.

Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×

Anesthesia endotracheal tube have gained tremendous demand in the recent years due to rise in the number of surgeries

 

Anesthesia is the key element to achieving pain relief in the surgical procedure. Anesthesia Endotracheal Tube is widely used in the management of uncomplicated trauma and acute surgical conditions such as heart attacks, asthma, COPD, and many other medical condition. The use of this equipment can dramatically increase the time to normal recovery and can eliminate the need for an early morning hospital stay. The risk factors for the administration of anesthesia are rare but can include allergic reactions, nausea, excessive bleeding, vomiting, and aspiration pneumonia. The most effective method of delivering an anesthetic is via the orogastric tube, which is inserted via the umbilical cord and the oropharynx.

An increasing number of surgical procedures is a prime factor driving the growth of the anesthesia endotracheal tube market. According to the American Society of Plastic Surgeons, in 2019, minimally invasive cosmetic procedures grew at a slightly higher rate than surgical procedures, and the total number of procedures increased for the third year in a row. 2019 marked the highest number of Botulinum toxin type A injections to date with over 7.69 million injections, and facial rejuvenation procedures are not showing signs of slowing down in 2020. The growing adoption of advanced medical technology in the health care sector coupled with the growing aging population which is increasing the prevalence of chronic disease and surgeries is again propelling the growth of the anesthesia endotracheal tube market.

North America is expected to exhibit significant growth over the forecast period and this is attributed to the high presence of chronic disease due to the increasing aging population in the region. This is driving a need for healthcare need such as surgeries and other treatments. According to the National Health Council, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of this country. By 2020, that number is projected to grow to an estimated 157 million, with 81 million having multiple conditions. According to the U.S. Census Bureau, there were 40.3 million U.S. residents 65 years and older in the 2010 Census and more than 54 million on July 1, 2019.

Key Players:

1.      Medline Industries

2.      Medtronic

3.      C. R. Bard

4.      ConvaTec

5.      GE Healthcare

6.      Smiths Medical

7.      KindWell Medical

8.      ROYAX

9.      Fuji Systems

10. Teleflex

11. Neurovision Medical

12. Intersurgical

Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×

Increasing Focus on Aesthetic Appeal to Augment Growth of Cosmetic Dentistry Market

 

Cosmetic dentistry is normally used to describe any type of dental work which improves the look of bite, gums, and teeth. It is also commonly used to describe any work done to improve the health of the mouth and to correct any abnormalities. Generally, cosmetic dentistry deals with aesthetic dental surgery, which aims at improving the 'appearance' of the teeth rather than their 'function'.

Market Dynamics

Increasing focus on aesthetic appeal is expected to propel growth of the cosmetic dentistry market. For instance, according to a 2018 survey by Global Data, around three quarters of South Korean men undertake a beauty or grooming treatment at least once a week. Moreover, increasing expenditure on personal care products is also expected to aid in growth of the market. For instance, according to the U.S. Bureau of Labor Statistics, average annual expenditure on personal care products in the U.S. increased from US$ 707 in 2016 to US$ 768 in 2018.  

Increasing geriatric population is expected to offer lucrative growth opportunities for players in the cosmetic dentistry market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034. Moreover, increasing number of dentists is also expected to aid in growth of the market. For instance, according to the American Dental Association, the number of dentists in office in the U.S. increased from 199,486 in 2018 to 200,419 in 2019.

Launch of virtual services during the COVID-19 pandemic is expected to aid in growth of the cosmetic dentistry market. For instance, in April 2020, Cigna Corporation, a U.S.-based health services organization, launched Dental Virtual Care, a virtual care solution, for dental issues during the COVID-19 pandemic.

Among regions, North America is expected to witness significant growth in the cosmetic dentistry market, owing to increasing number of dentist visits in the region. For instance, according to National Center for Health Statistics’ 2018 report, 84.9% of children aged 2-17 years visited a dentist in 2017, in the U.S. 

Competitive Analysis

Major players operating in the cosmetic dentistry market include, Danaher Corporation, Align Technology, Dentsply Sirona, 3M, Zimmer Biomet, Biocon, Shofu Dental Corporation, Thommen Medical, and Den Tech.

Major players in the cosmetic dentistry market are focused on launching new products to expand their product portfolio. For instance, in January 2020, Dentsply Sirona launched CEREC Primemill, a grinding and milling machine with 7-inch touch interface, an integrated camera for scanning blocks with compatible data matrix code, and an RFID scanner for reading tool information. 

Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×

Stomach Cancer Drugs Market Continues to Expand as South Korean Drug Manufacturer Celltrion Inc. Receives the WHO Prequalification Standards for its biosimilar

 

Stomach cancer is a growth of abnormal tissues that form a tumor in the part of your abdomen. Symptoms of stomach cancer often include persistent abdominal pain, extreme heartburn, extreme vomiting, severe indigestion, abdominal swelling, and frequent diarrhea. These symptoms are common for all forms of stomach cancer but when cancer spreads to the upper part of the chest, the symptoms become far more severe and may eventually cause death. Stomach cancer has the highest survival rate of any type of cancer in the world.  Crocetin (trade name Eulexin) is the first Stomach Cancer Drug that is used in the treatment of gastric cancer. It was later on approved for treating peritoneal mesothelioma but was not marketed extensively due to its negative outcomes at the beginning.

Increasing prevalence of stomach cancer is expected to drive growth of the global stomach cancer drugs market during the forecast period. According to the American Cancer Society (ACS), in 2020, around 27,600 new cases of stomach cancer are expected to be diagnosed in the U.S. According to the World Cancer Research Fund, in 2018, over 1 million new cases of cancer were diagnosed across the globe. Stomach cancer is the fourth most commonly occurring cancer in men and the seventh most commonly occurring cancer in women. As a result of this, the demand for stomach cancer drugs has increased significantly worldwide for adequate treatment options. Hence, these factors are expected to drive growth of the global stomach cancer drugs market during the forecast period. Moreover, the advent of the novel therapies for metastatic stomach cancer is expected to boost the global stomach cancer drugs market growth over the forecast period.

However, high cost associated with cancer therapy combined with side-effects of cancer drugs such as appetite loss, diarrhea, anemia, and constipation is expected to hamper the global stomach cancer drugs market growth over the forecast period. Among regions, Asia Pacific is expected to witness significant growth in the global stomach cancer drugs market during the forecast period. This is owing to the presence of a large patient pool across the region. Moreover, North America is expected to register a robust growth rate over the forecast period, owing to the presence of major market players such as Eli, Lily and Company, Merck, Novartis International AG, F. Hoffmann-La Roche Ltd., and Otsuka Holdings Co. Ltd.

Major companies involved in the global stomach cancer drugs market are Bristol-Myers Squibb, GlaxoSmithKline PLC, Celltrion Inc., Pfizer Inc., Sanofi, Eli, Lily and Company, Merck, Novartis International AG, F. Hoffmann-La Roche Ltd., and Otsuka Holdings Co. Ltd.

For instance, in August 2020, Celltrion Inc. received the World Health Organization (WHO) prequalification standards for its biosimilar Herzuma indicated for stomach and breast cancer. 

Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×

Increasing Focus on Aesthetic Appeal and Growing Geriatric Population to Augment Growth of Skin Rejuvenation Devices Market

 

Skin rejuvenation is basically a cosmetic surgery, which aims to bring about a more youthful appearance of the face. Various facial rejuvenation techniques can be used to accomplish this goal. Such procedures can range in depth and Invasiveness of treatment. It is important for you to understand the kind of skin care treatment that would be best suited for your specific goals and preferences.

Market Dynamics

Increasing focus on aesthetic appeal is expected to propel growth of the skin rejuvenation devices market. For instance, according to a 2018 survey by Global Data, around three quarters of South Korean men undertake a beauty or grooming treatment at least once a week. Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.

Increasing expenditure on personal care products is expected to offer lucrative growth opportunities for players in the skin rejuvenation devices market. For instance, according to the U.S. Bureau of Labor Statistics, average annual expenditure on personal care products in the U.S. increased from US$ 707 in 2016 to US$ 768 in 2018. Moreover, increasing adoption of facial rejuvenation is also expected to aid in growth of the market. For instance, according to International Society of Aesthetic Plastic Surgery, photo rejuvenation was one of the top five nonsurgical procedures for women while total facial rejuvenation accounted for 276,069 procedures in 2019.  

Among regions, North America is expected to witness significant growth in the skin rejuvenation devices market, owing to high prevalence of acne in the region. For instance, according to the American Academy of Dermatology 2018 report, acne is the most common skin condition in the U.S. affecting around 50 million peoples annually, which is expected to propel growth of the dermatology devices market.

Competitive Analysis

Major players operating in the skin rejuvenation devices market include, Cutera Inc., Hologic, Inc., Lutronic Corporation, Syneron Medical Ltd., Lumenis Ltd., Strata Skin Sciences, Inc., BISON MEDICAL, Solta Medical Inc., Lynton Lasers Ltd., and EL.En. S.p.A., Sciton, Inc., Fotona D.O.O. and Alma Lasers, Ltd.

Major players operating in the skin rejuvenation devices market are focused on approval and launch of new products to expand their product portfolio. For instance, in August 2020, Cutera, Inc. launched its new Fraxis PRO progressive dermal remodeling technology.

Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×

Increasing Demand for Release Liners in End-Use Industries to Augment the Release Liners Market Growth

 

Release liners are used to prevent a sticky surface from prematurely adhering. Release liners can be poly-coated-paper-based, film-based, and paper-based or sometimes contain unique substrates such as metalized films as their base. Release liners are coated (usually with silicone) on one or both sides with a release agent to provide a release effect against any type of viscous material such as mastic or an adhesive. Release liners are widely used in medical applications such as metalized films/papers as their base. Industrial application of liners covers roofing shingles, weatherproofing, and insulation products. Moreover, it plays an important role in the applications of self-adhesive products.

The increasing demand for industrial labels is primarily driving the growth of the release liners market. Labels account for a substantial share in the overall packaging industry. Furthermore, technological innovations such as bar codes, QR codes, RFID, and NFC display prices, details, instructions, and discount offers or coupons, as well as growing digitization, will further augment the release liners growth. Moreover, increasing demand/consumption of packaged food or the growing popularity of packaged food due to its large-scale benefits, including instant cooking, eating convenience, and the ready-to-eat alternative is also expected to propel the growth of the release liners market.

Apart from this, rapidly emerging/expanding pharmaceutical, cosmetic, personal care products, and automobile industries are also expected to boost the market growth. However, stringent government regulations regarding environmental sustainability are expected to restraint the growth of the market. The majority of the release liners are made of PVC and HDPE materials which are hazardous to the environment and can also affect human health. Strict FDA regulations and EU regulations have banned harmful materials such as PVC. In terms of geography, the market is divided into six regions, such as North America, Europe, Asia Pacific, South America, the Middle East, and Africa.

In 2018, Asia Pacific dominated the market, accounting for 32.0% of the market share in terms of revenue, followed by North America and Europe, respectively. Moreover, key players in the market are adopting various strategies (such as the development of next-generation release liners, expansion of production facilities, etc.) to meet the increasing demand for release liners. For instance, in 2017, Twin Rivers launched the next-generation of Alliance Release, a base paper used in the production of silicone-coated release liners. Moreover, in July 2018, ITASA opened a new production facility for silicone paper and film in Mexico to position itself in the emerging release liners market.

Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×

Surgical robots addresses complex surgeries effectively with the better precision and outcome

 

Surgical robots are designed to do much more than simple surgeries, including complex surgeries that are usually only done under very complicated circumstances. For example, a surgical robot that is used to help urologists insert hyaluronic acid pellets into the penis is able to perform this surgery without placing the patient at risk for any kind of infection.

Growing demand awareness regarding the advantages of robotic-assisted surgery coupled with the advancement in the surgery is fueling the market growth of surgical robots. Increasing adoption of surgical robots across hospitals & ambulatory surgery centers in order to reduce human error and improve patient safety is again driving the market growth of surgical robots. According to the International Federation of Robotics, the total value of sales of medical robots increased to US$1.9 billion, accounting for 29 percent of the total sales value of the professional service robots in 2017. Moreover, expanding application of surgical robots across various surgeries such as general surgery, gynecological surgery, urological surgery, neurosurgery, orthopedic surgery, and other applications is also expected to uplift the market growth. Growing focus on improving surgeries with better precision and outcome is further anticipated to bolster the market growth of surgical robots market growth. A rise in the funding in the field of surgical robots for developing more advanced cost-effective robots is anticipated to foster the market growth of the surgical robots.

North America is expected to gain significant growth over the forecast period and this is attributed to the increasing healthcare funding coupled with the rapid adoption of such advanced technology across the healthcare sector. According to the Centers for Medicare & Medicaid Services, the U.S. health care spending grew 4.6 percent in 2019, reaching US$3.8 trillion or US$11,582 per person.

Key Developments:

In September 2019, Medtronic has launched a new robot-assisted surgery platform that is more flexible and cost-effective than systems presently on the market.

In December 2020, Smith + Nephew (S+N) has announced the launch of a new handheld robotics platform: CORI. It is a surgeon-controlled handheld robotic platform, and its modular design will enable it to be scaled across the orthopedic service line.

In December 2019 Apollo Hospitals Bangalore has announced the launch of the first dedicated Robot-Assisted Cardiac Surgery Unit in India. The Robot-Assisted Cardiac Surgery Unit will offer patients with complex cardiac disease treatment with robotic-assisted minimally invasive cardiac surgery.

Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×

Emergence of Covid-19 to Offer Lucrative Growth Opportunities for Players in Protein A Resin Market

 

Protein A colorimetric resins are the most extensively used affinity purifiers in bio-manufacturing and other industries. Protein A colorimetry is a robust, high-throughput chromatography method and is used primarily as a capture step because of its inherent precision.

Market Dynamics

Approval and launch of new biosimilars is expected to propel growth of the protein A resin market. For instance, in December 2020, Sandoz Canada Inc., a generics and biosimilars manufacturer and a division of the Switzerland-based multinational Novartis AG, received Health Canada authorization for Hyrimoz (adalimumab injection, reference biologic drug: Humira) on November 4, 2020 for marketing in Canada. Hyrimoz, the new biosimilar, has been approved for the treatment of rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn’s disease, ulcerative colitis, hidradenitis suppurativa, psoriasis and adult uveitis.

Moreover, high prevalence of chronic diseases is also expected to aid in growth of the protein A resin market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Increasing adoption of chromatography resins is expected to propel growth of the protein A resin market. For instance, in March 2020, Purolite Ltd. announced to supply its Praesto Jetted A50, an agarose-based Protein A chromatography resin, for use as part of the commercial manufacturing process of an FDA-approved monoclonal antibody treatment by a contract manufacturing organization. Similarly, in November 2020, Purolite Ltd. announced to supply its Protein A capture resin, Praesto Jetted A50 to WuXi Biologics, a global company with leading open-access biologics technology, for immediate use. WuXi Biologics.

Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the protein A resin market. For instance, in October 2020, Repligen Corporation and Navigo Proteins GmbH, a premier protein engineering company, announced their successful development of an affinity ligand targeting the spike protein, to be utilized in the purification of COVID-19 vaccines.

Competitive Analysis

Major players operating in the global protein A resin market include, GE Healthcare, Thermo Fisher Scientific, Repligen, Avantor, Inc., Purolite Ltd., Tosoh Bioscience, EMD Millipore, Novasep, GenScript Biotech Corporation, Purolite Life Sciences, and Expedeon Ltd.

Major players operating in the global protein A resin market are focused on approval and launch of new products to expand their product portfolio. For instance, in March 2020, Avantor, Inc. launched a new recombinant Protein A affinity chromatography resin used to purify antibodies during mAbs production.

Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×

Cloud Deployment in the Healthcare Industry to Augment Growth of the Healthcare Cloud Computing Market

 

Cloud computing is a method to store and access data and programs over the internet. The term is generally used to describe data centers available to many users over the Internet. There are three main service models of cloud computing are Software as a Service (SaaS), Platform as a Service (PaaS), and Infrastructure as a Service (IaaS). Cloud computing helps the healthcare industry in many ways such as it helps share and store data, holds and provides more information at a lower cost, provides great reach during the times of disaster, and allows professionals to store and access data remotely, which helps to speed up the medical research.

Moreover, in healthcare, cloud computing makes medical record-sharing easy and secure, automates backend operations, and even facilitates the creation and maintenance of telehealth applications. Increasing cloud deployment in the healthcare industry and increasing adoption of IoT (Internet of Things) in healthcare, wearable devices, and big data analytics is expected to drive the growth of the healthcare cloud computing market. For instance, in December 2019, KCR adopted a cloud platform, Veeva Vault, for its clinical research programs. Internet adoption has increased over the years, doubled since 2010. Furthermore, better scalability, flexibility, and storage of data offered by cloud computing and the increasing penetration of the internet is expected to propel the market growth.

For instance, according to the internet live stats, more than 4.77 billion people (around 60% of the global population) were active internet users as of December 2020. However, the lack of adoption of the internet and lack of awareness in emerging regions is expected to impede market growth. For instance, China has a huge online community, yet its internet penetration is 65.6% (of the population). Moreover, the emergence of the telecloud, the use of blockchain in the health cloud, and the formation of accountable care organizations are expected to create significant growth opportunities for the healthcare cloud computing market. In terms of geography, the healthcare cloud computing market is divided into six regions, such as North America, Europe, Asia Pacific, South America, the Middle East, and Africa.

Asia Pacific is expected to witness robust growth in the market, owing to the increasing government initiatives for healthcare digitization, growing patient pool, and growing disease burden in the region. Moreover, telehealth and virtual care delivery options have subsequently increased as a result of the global pandemic (COVID-19 outbreak). Furthermore, key players active in the market are adopting various strategies (such as merger and acquisition, partnership, etc.) to enhance their market share, as well as expand their product portfolio. For instance, in February 2020, Sectra signed a ten-year contract with Region Halland to deliver its radiology imaging solution (RIS) as a cloud service.

Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×

Enteral feeding devices to gain significant demand in the near future due to increasing burden of chronic disease across developed countries

 

Enteral feeding devices technological advanced medical device used to deliver nutrition food directly to the stomach to the bedridden patient suffering from chronic diseases such as cancer and neurological disorder. 

 The increase in the cases of malnutrition and premature birth cases around the globe is a prime factor driving growth of the enteral feeding devices market. Moreover, the growing prevalence of chronic diseases such as cancer and cardiovascular disease is another key factor fostering the market growth of the enteral feeding devices. According to the World Health Organization, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths occur due to cancer. Around 70% of deaths from cancer occur in low- and middle-income countries. Furthermore, increasing global expenditure on the healthcare sector for improving the patient care is further projected to augment the growth of the enteral feeding devices market. 

 From the geographical perspective, North America is projected to gain significant growth over the forecast period and this is attributed to the high presence of the geriatric population prone to chronic disease that leads to digestive ailments. According to the U.S. Census Bureau, there were 40.3 million U.S. residents 65 years and older in the 2010 Census and more than 54 million on July 1, 2019. Also, the rising number of surgical and minimally invasive procedures in the region is further expected to accelerate the regional market growth of the enteral feed device. According to the American Society of Plastic Surgeons (ASPS) report, over 17.7 million cosmetic procedures and minimally-invasive cosmetic procedures were performed in the U.S. in 2018. 

 Key Developments:

1.      In October 2019, Fidmi Medical, a company based in Israel, won FDA clearance for its new low-profile enteral feeding device. The product is manufactured to help overcome many of the challenges presented by percutaneous endoscopic gastrostomy (PEG) tubes, especially dislodgements and clogging of the inside.

2.      In March 2019, Medline expanded its enteral feeding portfolio with the launch of new Blenderized Meals, Kitchen Blends. The new products complement Medline’s robust portfolio of nutrient supplements and devices for tube feeders. 

3.      In January 2017 Vygon, the single-use medical devices group announced the launch of easymoov6, a more intuitive enteral feeding pump. The device is connected via a tube to a nutrient bag and equipped with a digital interface, the pump supports the management of enteral feeding in both hospital and home care.

Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×

The Boom in Construction Industry to Augment the Cladding Systems Market Growth

 

Cladding is any particular material used to give a final finish to the building exteriors. The cladding system may or may not be waterproof, but it helps protect the building from wind, rain, dust, snow, and other external factors. It can be also used for a decorative purpose to make buildings visually appealing. They are also called curtain walls, building envelopes, or facade systems. Cladding systems are usually made up of durable and non-corrosive materials such as vinyl (plastic), bricks, precast concrete, tiles, glass, timber, metals, weatherboards, and stones. However, cladding materials have their advantages and properties. For instance, cladding systems can be combined with cavity walls for better thermal and noise insulation.

Moreover, the cladding systems are available in various styles, textures, finishes, colors, and varying strengths that make them compatible to withstand heavy winds and forces. With increasing construction activities worldwide, the need for appealing and energy-efficient structures has paved the way for the market. Moreover, the high-performance characteristics of the cladding system are also expected to drive the growth of the cladding systems market. For instance, in April 2019, Cembrit announced the launch of a new fiber cement cladding board ‘Patina Rough’, offering a new range of premium cladding for a wide variety of external applications.

High cost of installation and maintenance, as well as a shortage of raw material, is expected to hamper the cladding systems market growth. However, the growing need for better insulation and energy-efficient buildings increases the demand for better cladding options and innovations, creating significant growth opportunities for the market. Moreover, the increasing use of recycled plastic & metal and eco-friendly materials is making cladding systems more popular and reducing costs for manufacturing cladding, which is expected to propel the growth of the cladding systems market.

In terms of geography, the cladding systems market is divided into six regions, such as North America, Europe, Asia Pacific, South America, the Middle East, and Africa. North America and the Asia Pacific are the largest markets for cladding systems due to the rapid growth of the construction industry in these regions. Moreover, key players active in the market are focused on launching new and innovative cladding in the market. For instance, in 2019, Arcitell, in partnership with Hexion, launched a lightweight fiber-reinforced polymer panel, Qora cladding, in the market. While, in 2018, Ibstock Kevington launched a new lightweight cladding system, MechSlip, that offers the aesthetic appeal of real brick.

Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×